Friday July 18, 2014

ABK Biomedical Receives $2.14M in funding

Posted in: News

BOYNECLARKE LLP congratulates ABK Biomedical Inc. on being awarded $2.14 Million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF).

Founded by interventional radiologist, Dr. Bob Abraham and materials scientists Dr. Daniel Boyd and Dr. Sharon Kehoe, ABK Biomedical Inc. is a research and development company pursuing development, production and sale of embolic agents and peripheral vascular delivery devices.  ABK innovates integrated devices to simplify clinical procedures performed by interventional radiologists, with the lead system OccluRad /OccluDel, targeting hypervascular tumours including uterine fibroids.  The AIF funding will support the development and commercialization of biomaterials that will simplify and enhance the delivery of chemotherapy and radiotherapy for cancer patients.

Congratulations to ABK Biomedical on your recent success!

Share This Post:

Recent Blog Posts

News | Friday November 8, 2019

Bryen E. Mooney recognized as a leading lawyer in Canada

Posted in:

We are pleased to announce that Bryen E. Mooney was included in this year’s Lexpert Rising Stars: Leading Lawyers Under 40.

Read full article
News | Monday October 21, 2019

James D. MacNeil Named Fellow of Construction Lawyers Society of America

Posted in:

BOYNECLARKE LLP is pleased to announce that James D. MacNeil has been selected as a Fellow of the Construction Lawyers Society of America (CLSA).

Read full article
News | Tuesday October 8, 2019

John A. Young, Q.C. Receives Honorary Degree

Posted in:

BOYNECLARKE LLP congratulates John A. Young, Q.C. on receiving an honorary degree from Saint Mary’s University.

Read full article
News | Monday October 7, 2019

Terrance G. Sheppard Named Treasurer for the CBA Nova Scotia

Posted in:

Congratulations to Terrance G. Sheppard who was recently named as the Canadian Bar Association – Nova Scotia Branch Treasurer.

Read full article